Forward Citations = 14

Loading Chart...

6 inventors (with patents filed for the assignee):

Zaifang Ren (3 out of 5 patents)

Xuefeng Sun (3 out of 7 patents)

Qing Xu (3 out of 26 patents)

4. Jingye Zhou (2 out of 17 patents)

5. Jiuxiang Zhu (1 out of 8 patents)

6. Mingwei Zheng (1 out of 5 patents)

4 patents: Sort by Forward Citations

1. 11964942 - SSAO inhibitors and use thereof (2024-04-23),

2. 11780825 - Thyroid hormone receptor agonists and use thereof (2023-10-10),

3. 11584751 - Substituted imidazoles as GLP-1 receptor agonists (2023-02-21),

4. 11472769 - SSAO inhibitors and use thereof (2022-10-18),

Company Overview

Eccogene (shanghai) Co., Ltd. is a leading biotechnology company dedicated to providing innovative molecular diagnostic solutions. With a focus on research, development, and production, Eccogene offers a wide range of products for genetic testing, personalized medicine, and molecular diagnostics. Their cutting-edge technologies and advanced solutions have established them as a trusted partner in the healthcare industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#543 in Shanghai

#6,438 in China

Shanghai, China

Eccogene (Shanghai) Co., Ltd.

Forward Citations = 14

6 inventors:

Zaifang Ren (3 out of 5 patents)

Xuefeng Sun (3 out of 7 patents)

Qing Xu (3 out of 26 patents)

4. Jingye Zhou (2 out of 17 patents)

5. Jiuxiang Zhu (1 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Eccogene (Shanghai) Co., Ltd.. Retrieved from https://idiyas.com/company/eccogene-shanghai-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]